252 related articles for article (PubMed ID: 23757841)
1. [Inhibition of HIV-1 in vitro by combination of vpr and tat specific short hairpin RNA via lentiviral vectors].
Hao YZ; Teng ZP; Yang YS; Sun XN; Ma J; Jin XH; Zeng Y
Bing Du Xue Bao; 2013 Mar; 29(2):126-31. PubMed ID: 23757841
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.
Farazmandfar T; Haghshenas MR; Shahbazi M
Hum Gene Ther; 2015 Oct; 26(10):680-7. PubMed ID: 26077977
[TBL] [Abstract][Full Text] [Related]
3. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
[TBL] [Abstract][Full Text] [Related]
4. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
Anderson JS; Javien J; Nolta JA; Bauer G
Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
7. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration.
Nishitsuji H; Kohara M; Kannagi M; Masuda T
J Virol; 2006 Aug; 80(15):7658-66. PubMed ID: 16840344
[TBL] [Abstract][Full Text] [Related]
8. Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR.
Park J; Nadeau PE; Mergia A
Virus Res; 2009 Mar; 140(1-2):112-20. PubMed ID: 19110017
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
Morris KV; Rossi JJ
Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
[TBL] [Abstract][Full Text] [Related]
10. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
11. Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.
Hayes AM; Qian S; Yu L; Boris-Lawrie K
Retrovirology; 2011 May; 8():36. PubMed ID: 21569500
[TBL] [Abstract][Full Text] [Related]
12. ZBTB2 represses HIV-1 transcription and is regulated by HIV-1 Vpr and cellular DNA damage responses.
Bruce JW; Bracken M; Evans E; Sherer N; Ahlquist P
PLoS Pathog; 2021 Feb; 17(2):e1009364. PubMed ID: 33635925
[TBL] [Abstract][Full Text] [Related]
13. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells.
Nishitsuji H; Ikeda T; Miyoshi H; Ohashi T; Kannagi M; Masuda T
Microbes Infect; 2004 Jan; 6(1):76-85. PubMed ID: 14738896
[TBL] [Abstract][Full Text] [Related]
14. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
15. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
Poon B; Chang MA; Chen IS
J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
[TBL] [Abstract][Full Text] [Related]
16. Tat-regulated expression of RNA interference: triggers for the treatment of HIV infection.
Unwalla H; Rossi JJ
Curr HIV/AIDS Rep; 2008 Feb; 5(1):40-3. PubMed ID: 18417034
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr.
Pang S; Kang MK; Kung S; Yu D; Lee A; Poon B; Chen IS; Lindemann B; Park NH
Clin Cancer Res; 2001 Nov; 7(11):3567-73. PubMed ID: 11705878
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors for gene therapy of HIV-1 infection.
Mautino MR
Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
